Here, we tested TCS for the first time in various PCa cell lines and compared its cytotoxic potency and phenotypic effects on cell morphology, cell cycle, cellular lipid levels, and expression and regulation of key enzymes involved in energy homeostasis and FA synthesis to the well-known FASN inhibitors C75 and orlistat. The gene discussed is FASN; the disease is posterior cortical atrophy.